| Other pictures |
|
| Download | |
| Related Press Releases Links |
应世生物完成1.3亿元人民币A+轮融资，加速推进临床开发与管线布局 InxMed Announced the Completion of RMB 130M (~US$ 19M) Series A+ Financing to Accelerate Its Clinical Development and Strengthen Translational Capabilities |